ASH News Daily 2017 - Issue 3 - C-6
ASH News Daily
Page C-6
®
Monday, December 11, 2017
59th ASH Annual Meeting & Exposition
GE
NHLBI
Ferrata Storti
FoundationHaematologica
Journal
American Amyloidosis
Porphyria
Support
Foundation
Groups
Myeloma
Patients
Europe
Waldenstrom's
Macroblobulinemia
Foundation
Product
Theater 1
Product
Theater 2
addmedica
Impact
Biomedicines
Mediware
Prolong
Pharmaceuticals
951 1050
1046
Global Blood
Therapeutics
Mission
Bio, Inc
LeCancer. Fr/
Publiclin
Cleveland
Clinic
Taussig
Cancer
Institute
Hospital
Information
Services
Make-AWish
MPN
Research
Foundation
The Aflac Cancer
Center at
Children's
Healthcare of
Atlanta
St.
Baldrick's
Foundation
Foundation for
Women & Girls
with Blood
Disorders
16th Int'l
Myeloma
Workshop
NIDDK/NIH
Histiocytosis
Association
Histiocyte
Society
WizSolution
Research
The Japanese
Society of
Hematology
Amyloidosis
Research
Consortium
UF Health Cancer
Center-University
of Florida
Actinium
Pharmaceuticals
Platelet
Disorder
Support
Cincinnati
Children's
Diagonostic
Laboratories
Shands
Teaching
Hospital and
Clinics, Inc
Brazilian Assoc
of Hematology,
Hemotherapy and
Cellular Therapy
ABHH
American
Society for
Apheresis
(ASFA)
Midatech
Pharma
US, Inc
Dana-Farber/
Boston Childrens
Cancer and Blood
Disorders Center
Indo-American
Cancer Assoc
(IACA)
American
Board of
Internal
Medicine
Amyloidosis
Foundation
Sanofi
Genzyme
Dana-Farber
Cancer
Institute
Merck
Sanofi Genzyme
Janssen
Biotech Inc
National
Cancer
Institute
Bone Marrow
Transplantation
Associates
College of
Multiple
American
Myeloma Pathologists
Research
Foundation
Hemostasis
and Thrombosis
Research
Society, Inc.
(HTRS)
Int'l Society on
Thrombosis and
Haemostasis
AIDS and
Cancer Specimen
Resource
(ACSR)
MDS
Foundation
American Society
Of Pediatric
Hematology
Oncology
(ASPHO)
AABB
American
Assoc for
Cancer
ResearchAACR
Foundation for
the Accreditation
of Cellular
Therapy
Fanconi
Anemia
Research
Fund, Inc
HealthWell
Foundation
The
Leukemia
&
Lymphoma
Society
Bone Marrow
Transplantation
Information Net
The
Mastocytosis
Society
Foundation
for Sickle
Cell Disease
Research
SITC
Dysteratosis
Congenita
Outreach
ISH 2018
Seattle
Children's
Hospital
American Society
for Blood &
Marrow
Transplantation
(ASBMT)
European Lymphoma
Hematology Coalition
Associates
Fred Hutchinson
Cancer Research
Center-Seattle
Cancer Care
Alliance
Hematology
Specialist
Associates
Diamond
Blackfan
Anemia
Foundation
*Coole
Anem
Founda
Diamond
Blackfan
Anemia
Canada
Winship Ca
Institute of E
Univers
ShwachmanDiamond
Syndrome
Foundation
(SDSF)
Ohio Stat
University
Comprehen
Cancer Cen
The Jame
CIBMTR
Skyline
National
Marrow
Donor
Program/
Moffitt Be the
Cancer Match
Roswell
Cance
Institu
Cance
Genetic
Center
Turkish
Society of
Hematology
Chilter
Incyte Corp
Daiichi Sankyo
SiderAL Inc.
STEMCELL
Tech Inc
Olympus
USA Inc.
*Hold
949 1048
GBT-Grupo
Biotoscana
Navigate
BioPharma
Services, Inc
Helsinn
Resonance
Health Ltd
Alex's
Lemonade
Stand
Foundation
Emmaus
Medical,
Inc
Janssen
Pharmaceuticals
Adaptive
Biotechnologies
Corporation
Invivoscribe
Tech Inc
AMAG
Pharmaceuticals
Merck
Otsuka USA
Pharmaceutical
The Binding
Site, Inc
ASH BOULEVARD
Daiichi Sankyo
Spectrum
Pharmaceuticals
ADC
Therapeutics
Juno
Therapeutics
BMS / Pfizer
GSK
Novo
Nordisk,
Inc
NeoGenomics
Laboratories
Tecnofarma
S.A
Teva Oncology
Gilead Sciences,
Inc
DRG Int'l
Inc
TeraSera
Therapeutics
PSI CRO
Dev
PRA Health
Sciences
Med
Fusion
Springer
Healthcare
408
World
Myeloma
Forum
513
Harborside
Press, LLC
Elsevier Elsevier
Hypoxygen
Hematology
News
Outcome
Health
Studio ER
Congressional
Italian Society
of Hematology
Techcyte
Imedex
Premier
Research
Wolters
Kluwer
Boehringer
Ingelheim
Pharmaceuticals
Toledo
Pharmaceuticals
City of
Hope
Novartis Oncology
Oncology.tv
Sandoz, A
Novartis
Company
Seattle Genetics
HEMA
Biologics
EBSCO
Health
The Lynx
Group
Genoptix
A Novartis
Company
Dova
Pharmaceuticals
infoScript,
Powered by
ecoFiles
Entrance
Physicians'
Education Resource
Argon
Medical
Devices
BD
Biosciences
Clinical
Advances in
Hematology
and Oncology
Intrinsic
Life Sciences
Sarah Cannon
Research Institute
McGrawHill
Education
BioView
(USA)
The Blood and
Marrow Transplant
Program at Northside
Hospital
Assoc of Cape Cod
Haymarket
Quest
Diagnostics Oncology
Springer
Nature
49
Product
Theater 5
Exhibiting As .............................. Booth Number
3D Signatures, Inc. ......................................... 1217
A-B-C
AABB ............................................................... 1848
AbbVie ............................................................. 2632
ABHH .............................................................. 1747
Actinium Pharmaceuticals ............................ 1547
Adaptive Biotechnologies Corporation ........ 933
ADC Therapeutics............................................ 323
addmedica ......................................................... 445
Aegis Sciences ................................................. 2144
Agios Pharmaceuticals .................................. 2902
AIDS and Cancer
Specimen Resource (ACSR) ...................... 1740
Alexion Pharmaceuticals, Inc. ...................... 2932
Alex's Lemonade Stand Foundation ........... 1652
Alnylam Pharmaceuticals, Inc. .................... 2955
Alphamed Press / The Oncologist ................ 607
AMAG Pharmaceuticals, Inc. ....................... 1332
American Association for
Cancer Research .......................................... 1840
American Board of Internal Medicine......... 1745
American Porphyria Foundation ................. 1757
American Society for Apheresis (ASFA) ..... 1846
American Society for Blood &
Marrow Transplantation (ASBMT) ........... 1947
American Society of Hematology ................ 1933
American Society of Pediatric
Hematology Oncology (ASPHO) ............. 1741
American Society of Hematology
Booth #1933
Amgen ............................................................... 703
Amyloidosis Foundation .............................. 1844
Amyloidosis Research Consortium ............. 1649
Amyloidosis Support Groups, Inc. .............. 1856
Aplastic Anemia and MDS
International Foundation, Inc.................... 1614
Apobiologix .................................................... 3221
ApoPharma, Inc.............................................. 3232
ArcherDX, Inc. ................................................ 3342
Argon Medical Devices, Inc. ............................. 32
AROG Pharmaceuticals and
Mentrik Biotech ........................................... 2848
Associates of Cape Cod, Inc. ............................ 44
Astellas Pharma US, Inc. ............................... 2007
AstraZeneca .................................................... 2505
Asuragen, Inc. ................................................. 2561
Axiom Real-Time Metrics, Inc. ..................... 3033
AYOXXA Biosystems GmbH ........................ 2662
Bayer HealthCare Pharmaceuticals, Inc...... 1823
BD ......................................................................... 33
Beckman Coulter Life Sciences .................... 2750
Biocytogen LLC .............................................. 2146
BioLegend, Inc. ............................................... 2501
Takeda
Oncolog
Prothena
TG
Therapeutics
The Jama
Network
Aplastic
Anemia
and MDS
Int'l
Foundation
UT MD
Anderson
Cancer
Center
Amgen
Alphamed
Press/
The
Oncologist
World Health
Organization
Press
Novella
Clinical
Int'l
Myeloma
Foundation
Genohm Inc.
Tempus
3D
Signatures
Inc
Intellisphere
EZLife
Bio
MaxCyte Cmed
Inc
Group
Promega
Corporation
Celgene Corp
Repertoire
Genesis
Bayer
HealthCare
Pharmaceuticals
Inc
Biologics Prescribers Collaborative ............. 1761
Bio-Rad Laboratories ..................................... 3049
Bioverativ .........................................................3112
BioView (USA), Inc. ........................................... 42
Blood & Marrow Transplant
Information Network ................................. 1953
BloodCenter of Wisconsin............................. 2463
bluebird bio ..................................................... 2949
BMS / Pfizer ..................................................... 823
Boehringer Ingelheim Pharmaceuticals, Inc. ..602
Bone Marrow Transplantation Association ..1645
BPL ................................................................... 2154
Bristol-Myers Squibb ......................................2811
Cancer Genetics, Inc. ..................................... 2043
Caprico Biotechnologies, Inc. ....................... 2653
Celgene Corporation ..................................... 1005
Champions Oncology .................................... 2754
Charter Medical Ltd....................................... 2756
Chiltern ............................................................ 2041
CIBMTR (Center for International Blood
& Marrow Transplant Research) ............... 2046
Cincinnati Children's Diagnostic
Laboratories ................................................. 1647
City of Hope National Medical Center ....... 1912
Cleveland Clinic Taussig Cancer Institute.. 1040
Clinical Advances in Hematology
and Oncology................................................... 34
Cmed Group Ltd .............................................. 512
College of American Pathologists ................ 1742
Conversant Bio ............................................... 2140
Cooley's Anemia Foundation ....................... 2055
Astell
Pharm
Table of Contents for the Digital Edition of ASH News Daily 2017 - Issue 3
ASH News Daily 2017 - Issue 3 - A-1
ASH News Daily 2017 - Issue 3 - A-2
ASH News Daily 2017 - Issue 3 - A-3
ASH News Daily 2017 - Issue 3 - A-4
ASH News Daily 2017 - Issue 3 - A-5
ASH News Daily 2017 - Issue 3 - A-6
ASH News Daily 2017 - Issue 3 - A-7
ASH News Daily 2017 - Issue 3 - A-8
ASH News Daily 2017 - Issue 3 - A-9
ASH News Daily 2017 - Issue 3 - A-10
ASH News Daily 2017 - Issue 3 - A-11
ASH News Daily 2017 - Issue 3 - A-12
ASH News Daily 2017 - Issue 3 - A-13
ASH News Daily 2017 - Issue 3 - A-14
ASH News Daily 2017 - Issue 3 - A-15
ASH News Daily 2017 - Issue 3 - A-16
ASH News Daily 2017 - Issue 3 - A-17
ASH News Daily 2017 - Issue 3 - A-18
ASH News Daily 2017 - Issue 3 - A-19
ASH News Daily 2017 - Issue 3 - A-20
ASH News Daily 2017 - Issue 3 - A-21
ASH News Daily 2017 - Issue 3 - A-22
ASH News Daily 2017 - Issue 3 - A-23
ASH News Daily 2017 - Issue 3 - A-24
ASH News Daily 2017 - Issue 3 - A-25
ASH News Daily 2017 - Issue 3 - A-26
ASH News Daily 2017 - Issue 3 - A-27
ASH News Daily 2017 - Issue 3 - A-28
ASH News Daily 2017 - Issue 3 - B-1
ASH News Daily 2017 - Issue 3 - B-2
ASH News Daily 2017 - Issue 3 - B-3
ASH News Daily 2017 - Issue 3 - B-4
ASH News Daily 2017 - Issue 3 - B-5
ASH News Daily 2017 - Issue 3 - B-6
ASH News Daily 2017 - Issue 3 - B-7
ASH News Daily 2017 - Issue 3 - B-8
ASH News Daily 2017 - Issue 3 - B-9
ASH News Daily 2017 - Issue 3 - B-10
ASH News Daily 2017 - Issue 3 - B-11
ASH News Daily 2017 - Issue 3 - B-12
ASH News Daily 2017 - Issue 3 - B-13
ASH News Daily 2017 - Issue 3 - B-14
ASH News Daily 2017 - Issue 3 - B-15
ASH News Daily 2017 - Issue 3 - B-16
ASH News Daily 2017 - Issue 3 - B-17
ASH News Daily 2017 - Issue 3 - B-18
ASH News Daily 2017 - Issue 3 - B-19
ASH News Daily 2017 - Issue 3 - B-20
ASH News Daily 2017 - Issue 3 - B-21
ASH News Daily 2017 - Issue 3 - B-22
ASH News Daily 2017 - Issue 3 - B-23
ASH News Daily 2017 - Issue 3 - B-24
ASH News Daily 2017 - Issue 3 - B-25
ASH News Daily 2017 - Issue 3 - B-26
ASH News Daily 2017 - Issue 3 - B-27
ASH News Daily 2017 - Issue 3 - B-30
ASH News Daily 2017 - Issue 3 - B-31
ASH News Daily 2017 - Issue 3 - B-32
ASH News Daily 2017 - Issue 3 - B-33
ASH News Daily 2017 - Issue 3 - B-34
ASH News Daily 2017 - Issue 3 - B-35
ASH News Daily 2017 - Issue 3 - B-36
ASH News Daily 2017 - Issue 3 - B-37
ASH News Daily 2017 - Issue 3 - B-38
ASH News Daily 2017 - Issue 3 - B-39
ASH News Daily 2017 - Issue 3 - B-40
ASH News Daily 2017 - Issue 3 - B-41
ASH News Daily 2017 - Issue 3 - B-42
ASH News Daily 2017 - Issue 3 - B-43
ASH News Daily 2017 - Issue 3 - B-44
ASH News Daily 2017 - Issue 3 - B-45
ASH News Daily 2017 - Issue 3 - B-46
ASH News Daily 2017 - Issue 3 - B-47
ASH News Daily 2017 - Issue 3 - B-48
ASH News Daily 2017 - Issue 3 - B-49
ASH News Daily 2017 - Issue 3 - B-50
ASH News Daily 2017 - Issue 3 - B-51
ASH News Daily 2017 - Issue 3 - B-52
ASH News Daily 2017 - Issue 3 - B-53
ASH News Daily 2017 - Issue 3 - B-54
ASH News Daily 2017 - Issue 3 - B-55
ASH News Daily 2017 - Issue 3 - B-56
ASH News Daily 2017 - Issue 3 - C-1
ASH News Daily 2017 - Issue 3 - C-2
ASH News Daily 2017 - Issue 3 - C-3
ASH News Daily 2017 - Issue 3 - C-4
ASH News Daily 2017 - Issue 3 - C-5
ASH News Daily 2017 - Issue 3 - C-6
ASH News Daily 2017 - Issue 3 - C-7
ASH News Daily 2017 - Issue 3 - C-8
ASH News Daily 2017 - Issue 3 - C-9
ASH News Daily 2017 - Issue 3 - C-10
ASH News Daily 2017 - Issue 3 - C-11
ASH News Daily 2017 - Issue 3 - C-12
ASH News Daily 2017 - Issue 3 - C-13
ASH News Daily 2017 - Issue 3 - C-14
ASH News Daily 2017 - Issue 3 - C-15
ASH News Daily 2017 - Issue 3 - C-16
ASH News Daily 2017 - Issue 3 - C-17
ASH News Daily 2017 - Issue 3 - C-18
ASH News Daily 2017 - Issue 3 - C-19
ASH News Daily 2017 - Issue 3 - C-20
ASH News Daily 2017 - Issue 3 - C-21
ASH News Daily 2017 - Issue 3 - C-22
ASH News Daily 2017 - Issue 3 - C-23
ASH News Daily 2017 - Issue 3 - C-24
ASH News Daily 2017 - Issue 3 - C-25
ASH News Daily 2017 - Issue 3 - C-26
ASH News Daily 2017 - Issue 3 - C-27
ASH News Daily 2017 - Issue 3 - C-28
ASH News Daily 2017 - Issue 3 - C-29
ASH News Daily 2017 - Issue 3 - C-30
ASH News Daily 2017 - Issue 3 - C-31
ASH News Daily 2017 - Issue 3 - C-32
https://www.nxtbookmedia.com